Homopeptide declines, for the 21st time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
April 2024 — Vol. 1, No. 4
Page 3 of 4 of this archive, newest first.
Also filed — page 3
the rolling newsroom, April 2024Independent analysis puts a WXT semaglutide lot at 98.0%, against 95.7% on the certificate
The result is unremarkable. What the report omits is not.
Inspectors cite the online reseller trading as Adamant Research Supply over sterility assurance
The observation that closes a facility is rarely the dramatic one.
The 23-day notice: how a compounding wind-down works in the United Kingdom
The document is four pages. Three of them are about dates.
STEP 2 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
VendorInvestigate result on a Wuhan orforglipron lot lands 3.8 points below the supplier’s figure
The supplier has not disputed the finding. It has not explained the gap either.
The relabeller trading as Vantris Bio enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
A supplier suspends shipping to South Africa after 14 consecutive customs detentions
The route did not close because of a rule about peptides.
What the new Ireland guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
From the floor in Guangzhou: 10 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Inspectors cite the consolidator trading as Meridian Freight Partners over sterility assurance
The observation that closes a facility is rarely the dramatic one.
The 14-day notice: how a compounding wind-down works in Denmark
The document is four pages. Three of them are about dates.
The quiet end of the relabeller trading as Vantris Bio
A proper account of an operation that existed, and of what closing it cost.
Independent analysis puts a GL Biochem tirzepatide lot at 96.7%, against 95.9% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
SURMOUNT-1 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The relabeller trading as Vantris Bio closes after 3 years
A proper account of an operation that existed, and of what closing it cost.
PeptideMeter result on a Zhuhai cagrilintide lot lands 1.5 points below the supplier’s figure
The report states the gradient, the wavelength and the integration threshold, which is more than most.
SURPASS-2 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Ireland pharmacy body issues counselling standards for semaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
Spain pharmacy body issues counselling standards for semaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
What a 13% rise in coupling-reagent prices does to a 15 mg vial
Follow the resin, not the catalogue.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
The 28-day notice: how a compounding wind-down works in Brazil
The document is four pages. Three of them are about dates.
Wuhan export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
South Africa health authority warns on falsified liraglutide pens
Reported from the analysis, not from a warning notice.
Calder Vale Peptides of Skipton enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
What changed at MKM in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
SURPASS-3 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.